Investigational small molecules in phase II clinical trials for the treatment of epilepsy: cannabidivarin, selurampanel (BGG492) and ganaxolone
| Image |  |
|---|---|
| Description | scientific article published on 13 November 2018 |
| Author/s |
author: Giangennaro Coppola |
| Publication date | November 13, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |